Discover
FDMT
4D Molecular Therapeutics, Inc.
14.11
2 x 10.44
1 x 14.14
bid
ask
-
0.56
3.82%
2 @ 04:00 PM
14.11 +0.00 (0.00%)
| Ytd | 88.13% | |
| 1y | 129.06% |
13.66
day range
14.60
5.97
52 week range
16.93
| Open | 14.49 | Prev Close | 14.67 | Low | 13.66 | High | 14.60 | Mkt Cap | 779.50M |
| Vol | 1.40M | Avg Vol | 955.83K | EPS | -2.63 | P/E | N/A | Forward P/E | -1.79 |
| Beta | 2.73 | Short Ratio | 9.86 | Inst. Own | 115.21% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-10 | 50-d Avg | 12.23 | 200-d Avg | 10.02 | 1yr Est | 42.64 |
| Income Statement | |||
| Total Revenue | 3.78M | ||
| Revenues (USD) | 3.78M | ||
| Gross Profit | 3.78M | ||
| Operating Expenses | 80.81M | ||
| Research and Development Expense | 68.28M | ||
| Selling, General and Administrative Expense | 12.52M | ||
| Operating Income | -77.03M | ||
| Net Income | -72.94M | ||
| Net Income Common Stock | -72.94M | ||
| Net Income Common Stock (USD) | -72.94M | ||
| Consolidated Income | -72.94M | ||
| Earnings per Basic Share | -1.04 | ||
| Earnings per Basic Share (USD) | -1.04 | ||
| Earnings per Diluted Share | -1.04 | ||
| Earning Before Interest & Taxes (EBIT) | -72.94M | ||
| Earning Before Interest & Taxes (USD) | -72.94M | ||
| Weighted Average Shares | 70.27M | ||
| Weighted Average Shares Diluted | 70.27M | ||
| Balance Sheet | |||
| Cash and Equivalents | 70.37M | ||
| Cash and Equivalents (USD) | 70.37M | ||
| Investments | 360.26M | ||
| Investments Current | 290.96M | ||
| Investments Non-Current | 69.30M | ||
| Trade and Non-Trade Receivables | 4.61M | ||
| Current Assets | 382.96M | ||
| Property, Plant & Equipment Net | 28.93M | ||
| Total Assets | 492.62M | ||
| Debt Current | 5.37M | ||
| Total Debt | 39.22M | ||
| Current Liabilities | 47.67M | ||
| Debt Non-Current | 33.84M | ||
| Total Liabilities | 84.96M | ||
| Accumulated Retained Earnings (Deficit) | -858.00M | ||
| Accumulated Other Comprehensive Income | -446.00K | ||
| Shareholders Equity | 407.66M | ||
| Shareholders Equity (USD) | 407.66M | ||
| Assets Non-Current | 109.66M | ||
| Total Debt (USD) | 39.22M | ||
| Deferred Revenue | 7.30M | ||
| Liabilities Non-Current | 37.28M | ||
| Trade and Non-Trade Payables | 12.52M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.09M | ||
| Net Cash Flow from Financing | 42.34M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.12M | ||
| Capital Expenditure | -66.00K | ||
| Issuance (Purchase) of Equity Shares | 23.08M | ||
| Issuance (Repayment) of Debt Securities | 19.26M | ||
| Net Cash Flow from Investing | 25.54M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 25.61M | ||
| Net Cash Flow from Operations | -70.00M | ||
| Share Based Compensation | 5.88M | ||